Are peptides legal in Canada?

Classification follows representation

The Food and Drugs Act defines a drug by purpose, not by chemistry. A substance falls under the definition when it is sold or represented for use in diagnosing, treating, mitigating or preventing a disease, or in restoring, correcting or modifying an organic function in humans or animals. The test is what the substance is held out as being for.

That is why the same molecule can sit in two places. Sold as a therapy, represented for human use, with a dose and an indication, it is a drug and it requires authorisation from Health Canada before it may be sold. Sold as a reference material for in vitro laboratory work, labelled for research use only, and not represented for any human or veterinary purpose, it is not being offered as a drug, and the authorisation framework for drugs is not what applies to it.

What a research-use label does not do

It does not change the molecule, and it does not make human use lawful. This is the part the category routinely blurs, so it is worth stating plainly: a research-use designation describes the basis on which something is sold. It is not a loophole, an exemption, or a form of permission. If a compound is represented for human use — by the seller in its marketing, or by the buyer in what they do with it — the representation changes and so does the law that applies.

A supplier that labels a product for research use while writing dosing protocols, publishing “cycle” guidance or implying a therapeutic result has represented it for human use regardless of what the label says. That is why nothing on this site carries dosing guidance, administration instructions or a claimed outcome.

Controlled substances are a separate question

The Controlled Drugs and Substances Act operates independently of all of the above. A scheduled substance is controlled whatever it is sold for, and research use is not a defence to possessing one without authorisation. Nothing listed in this catalogue is a controlled substance under the CDSA, and scheduled compounds are not stocked and are not available by request.

Prescription drugs are a third category again. A substance on the Prescription Drug List may not be sold without a prescription regardless of the purchaser’s intent, and those are likewise not stocked here.

What this means for ordering

The framework above turns on what a compound is represented for, which is why the labelling on this catalogue is written the way it is: these are reference materials for in vitro laboratory research, nothing here is scheduled under the CDSA or listed on the Prescription Drug List, and no dosing, protocol or administration guidance is published for any of it.

Everything is stocked and dispatched within Canada, so an order placed before the afternoon cut-off goes out the same day and arrives in two to five business days. See shipping for the dispatch cut-off and transit window, and buying peptides in Canada for how the catalogue is priced.

What this page is not

It is a description of a regulatory framework, written to be accurate and readable. It is not legal advice, it is not specific to your circumstances, and it does not establish any relationship between you and us beyond that of buyer and seller. If the answer matters to a decision you are making, the person to ask is a Canadian regulatory lawyer, and the authoritative source is Health Canada rather than a supplier’s website — including this one.